India, May 12 -- A study published in the medical journal Science Progress examined the link between GLP-1 medications and hair loss among patients undergoing rapid weight loss, NewsNation reports. A... Read More
India, May 12 -- Indian shares opened lower on Tuesday, extending steep losses from the previous session as investors fretted about the potential impact of surging crude oil prices and a weakening rup... Read More
India, May 12 -- Santos (STO.AX) has announced a final investment decision to proceed with the Agogo Production Facility Tie-In Project in Papua New Guinea, following approval by the PNG LNG joint ven... Read More
India, May 12 -- Tuesday, Scout24 SE (G24.DE, SCOTF.PK) announced an updated financial framework aligned with its growth strategy, revising its revenue growth framework to the high end of high single-... Read More
India, May 12 -- Bryan Adams' biggest hit, "(Everything I Do) I Do It For You," has joined the billion views club on YouTube. The song becomes Bryan's second video to hit that mark, following the cli... Read More
India, May 12 -- BMO Financial Group (BMO.TO,BMO) announced the signing of a definitive agreement with Stonepeak for the sale of BMO's Transportation Finance and Vendor Finance businesses, including r... Read More
India, May 11 -- Babcock & Wilcox Enterprises, Inc. (BW) shares soared 25.79 percent to $18.29, up $3.75 on Monday, after the company reported strong first-quarter revenue growth despite a wider net l... Read More
India, May 11 -- Galectin Therapeutics Inc. (GALT), a clinical-stage biotechnology company, on Monday published promising results from the Phase 2b NAVIGATE trial for belapectin in treating MASH cirrh... Read More
India, May 11 -- Mirae Asset Securities (00680K.KS) reported that its first quarter net income attributable to shareholders of the parent company came to 996.25 billion Korean won, up 285.0% compared ... Read More
India, May 11 -- BridgeBio Pharma Inc. (BBIO), a commercial-stage biopharmaceutical company, on Monday announced new data from its Phase 3 ATTRibute-CM study of Acoramidis, demonstrating disease-modif... Read More